China's drug regulator granted Shanghai Pharmaceuticals (SHA:601607) subsidiary Shanghai Shangyao Xinyi Pharmaceutical Factory a supplementary approval for azathioprine tablets, according to a Tuesday disclosure to the Shanghai bourse.
Azathioprine is used with corticosteroids and other immunosuppressants to prevent organ rejection for transplant patients, according to the filing.